A prospective, randomized trial with quadruple versus dual tacrolimus-based induction after liver transplantation.
Langrehr
J M
JM
Department of Surgery, Charité Campus Virchow-Klinikum, Humboldt-University Berlin, Berlin, Germany.
Klupp
J
J
Pfitzmann
R
R
Neumann
U
U
Lohmann
R
R
Jonas
S
S
Neuhaus
R
R
Steinmüller
T
T
Neuhaus
P
P
D000961:Antilymphocyte Serum / Q000627:therapeutic use; D001379:Azathioprine / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005500:Follow-Up Studies; D005938:Glucocorticoids / Q000627:therapeutic use; D006084:Graft Rejection / Q000517:prevention & control*; D006085:Graft Survival; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D016031:Liver Transplantation / Q000276:immunology*; D011239:Prednisolone / Q000627:therapeutic use; D011446:Prospective Studies; D016559:Tacrolimus / Q000627:therapeutic use
D000961:Antilymphocyte Serum; D005938:Glucocorticoids; D007166:Immunosuppressive Agents; D011239:Prednisolone; D001379:Azathioprine; D016559:Tacrolimus